Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
002389.SZ Stock Summary
In the News
002389.SZ Financial details
Company Rating
Neutral
Market Cap
15.05B
Income
153.47M
Revenue
2.86B
Book val./share
8.17
Cash/share
1.99
Dividend
0.06
Dividend %
0.35%
Employees
2.11K
Optionable
No
Shortable
Yes
Earnings
29 Apr 2024
P/E
45.8
Forward P/E
-
PEG
-9.23
P/S
5.12
P/B
2.06
P/C
8.29
P/FCF
-39.9
Quick Ratio
2.79
Current Ratio
3.45
Debt / Equity
0.11
LT Debt / Equity
0
-
-
EPS (TTM)
0.16
EPS next Y
-
EPS next Q
-
EPS this Y
-48.39%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-8.54%
Revenue last 5Y
-1.71%
Revenue Q/Q
97.06%
EPS Q/Q
-58.3%
-
-
-
-
SMA20
-
SMA50
6.67%
SMA100
-20%
Inst Own
-
Inst Trans
-
ROA
4%
ROE
5%
ROC
0.05%
Gross Margin
26%
Oper. Margin
11%
Profit Margin
10%
Payout
18%
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
11.52-23.03
52W High
-28.26%
52W Low
+50%
RSI
50
Rel Volume
2.38
Avg Volume
15.8M
Volume
37.63M
Perf Week
5.43%
Perf Month
5.5%
Perf Quarter
-13.43%
Perf Half Y
-20.14%
-
-
-
-
Beta
0.767
-
-
Volatility
0.58%, 0.67%
Prev Close
6.18%
Price
16.5
Change
9.42%
002389.SZ Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-12-31
Metric | History | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 3.34 | 3.16 | 3.08 | 3.93 | 2.9 | |
Net income per share | 0.25 | 0.29 | 0.24 | 0.31 | 0.16 | |
Operating cash flow per share | 0.35 | 0.43 | 0.04 | 0.48 | 0.41 | |
Free cash flow per share | 0.2 | 0.17 | -0.17 | 0.11 | 0.08 | |
Cash per share | 0.56 | 0.6 | 1.46 | 1.89 | 1.99 | |
Book value per share | 6.93 | 6.99 | 8.15 | 8.02 | 8.17 | |
Tangible book value per share | 4.91 | 5.1 | 6.37 | 6.19 | 6.34 | |
Share holders equity per share | 6.93 | 6.99 | 8.15 | 8.02 | 8.17 | |
Interest debt per share | 0.48 | 0.31 | 0.29 | 0.26 | 0.9 | |
Market cap | 10.3B | 31.46B | 26.3B | 20.21B | 18.27B | |
Enterprise value | 10.04B | 31B | 24.82B | 18.98B | 17.19B | |
P/E ratio | 44.4 | 114.83 | 115.57 | 65.89 | 119.05 | |
Price to sales ratio | 3.32 | 10.53 | 9.03 | 5.24 | 6.42 | |
POCF ratio | 32.01 | 76.61 | 687.48 | 42.66 | 45.58 | |
PFCF ratio | 55.46 | 197.38 | -159.6 | 179.62 | 235.09 | |
P/B Ratio | 1.6 | 4.76 | 3.41 | 2.56 | 2.28 | |
PTB ratio | 1.6 | 4.76 | 3.41 | 2.56 | 2.28 | |
EV to sales | 3.24 | 10.37 | 8.52 | 4.92 | 6.04 | |
Enterprise value over EBITDA | 15.71 | 55.37 | 47.16 | 29.52 | 36.53 | |
EV to operating cash flow | 31.23 | 75.5 | 648.81 | 40.07 | 42.9 | |
EV to free cash flow | 54.11 | 194.52 | -150.63 | 168.69 | 221.25 | |
Earnings yield | 0.02 | 0.01 | 0.01 | 0.02 | 0.01 | |
Free cash flow yield | 0.02 | 0.01 | -0.01 | 0.01 | 0 | |
Debt to equity | 0.07 | 0.04 | 0.03 | 0.03 | 0.11 | |
Debt to assets | 0.05 | 0.03 | 0.03 | 0.03 | 0.08 | |
Net debt to EBITDA | -0.39 | -0.81 | -2.81 | -1.91 | -2.29 | |
Current ratio | 2.57 | 2.47 | 4.18 | 3.77 | 2.75 | |
Interest coverage | 20.9 | 32.72 | 50.56 | 47.14 | 26.04 | |
Income quality | 1.26 | 1.37 | 0.16 | 1.51 | 2.61 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0.2 | 0.14 | 0.19 | 0.22 | 0.39 | |
Sales general and administrative to revenue | 0.01 | 0.01 | 0.01 | 0.02 | 0.02 | |
Research and developement to revenue | 0.05 | 0.05 | 0.06 | 0.04 | 0.04 | |
Intangibles to total assets | 0.25 | 0.22 | 0.2 | 0.2 | 0.19 | |
Capex to operating cash flow | -0.42 | -0.61 | -5.31 | -0.76 | -0.81 | |
Capex to revenue | -0.04 | -0.08 | -0.07 | -0.09 | -0.11 | |
Capex to depreciation | -0.58 | -1.11 | -0.81 | -1.53 | -1.25 | |
Stock based compensation to revenue | 0.01 | 0.01 | 0.01 | 0.01 | -0.23 | |
Graham number | 6.24 | 6.75 | 6.64 | 7.51 | 5.36 | |
ROIC | 0.05 | 0.04 | 0.03 | 0.04 | 0.02 | |
Return on tangible assets | 0.04 | 0.04 | 0.03 | 0.04 | 0.02 | |
Graham Net | 1.08 | 1.1 | 2.18 | 2.63 | 2.52 | |
Working capital | 2.29B | 2.62B | 3.97B | 4.03B | 4.01B | |
Tangible asset value | 4.55B | 4.82B | 6.03B | 6.08B | 6.22B | |
Net current asset value | 2.17B | 2.38B | 3.6B | 3.7B | 3.9B | |
Invested capital | 0.07 | 0.04 | 0.03 | 0.03 | 0.11 | |
Average receivables | 2.2B | 2.66B | 2.76B | 2.7B | 3.03B | |
Average payables | 824.06M | 1.05B | 1.13B | 1.01B | 1.06B | |
Average inventory | 528.44M | 576.25M | 670.69M | 768.05M | 893.74M | |
Days sales outstanding | 281.04 | 358.13 | 323.45 | 267.46 | 414.26 | |
Days payables outstanding | 136.13 | 204.4 | 168.19 | 119.53 | 179.07 | |
Days of inventory on hand | 89.83 | 97.66 | 122.99 | 94.85 | 159.2 | |
Receivables turnover | 1.3 | 1.02 | 1.13 | 1.36 | 0.88 | |
Payables turnover | 2.68 | 1.79 | 2.17 | 3.05 | 2.04 | |
Inventory turnover | 4.06 | 3.74 | 2.97 | 3.85 | 2.29 | |
ROE | 0.04 | 0.04 | 0.03 | 0.04 | 0.02 | |
Capex per share | -0.15 | -0.27 | -0.21 | -0.37 | -0.33 |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q4
Metric | History | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 1.78 | 0.52 | 0.64 | 0.59 | 1.16 | |
Net income per share | 0.22 | 0.02 | 0.1 | 0.03 | 0.01 | |
Operating cash flow per share | 0.22 | 0.02 | -0.15 | -0.14 | 1 | |
Free cash flow per share | -0.06 | 0 | -0.18 | -0.21 | 0.78 | |
Cash per share | 1.89 | 1.56 | 1.34 | 1.12 | 1.99 | |
Book value per share | 8.06 | 8.06 | 8.1 | 8.14 | 8.17 | |
Tangible book value per share | 6.21 | 6.22 | 6.27 | 6.27 | 6.34 | |
Share holders equity per share | 8.06 | 8.06 | 8.1 | 8.14 | 8.17 | |
Interest debt per share | 0.26 | 0.25 | 0.26 | 0.27 | 0.89 | |
Market cap | 20.12B | 22.28B | 21.82B | 19.33B | 18.27B | |
Enterprise value | 18.9B | 21.28B | 20.86B | 18.74B | 17.19B | |
P/E ratio | 23.14 | 298.66 | 57.18 | 173.62 | 393.82 | |
Price to sales ratio | 11.56 | 43.76 | 34.75 | 33.36 | 16 | |
POCF ratio | 92.58 | 1.19K | -144.72 | -141.55 | 18.61 | |
PFCF ratio | -320.07 | 15.87K | -123.39 | -94.15 | 23.71 | |
P/B Ratio | 2.55 | 2.82 | 2.74 | 2.42 | 2.28 | |
PTB ratio | 2.55 | 2.82 | 2.74 | 2.42 | 2.28 | |
EV to sales | 10.86 | 41.8 | 33.23 | 32.34 | 15.06 | |
Enterprise value over EBITDA | 65.88 | 854.19 | 193.65 | 573.7 | 166.24 | |
EV to operating cash flow | 86.92 | 1.14K | -138.38 | -137.21 | 17.52 | |
EV to free cash flow | -300.52 | 15.16K | -117.99 | -91.27 | 22.32 | |
Earnings yield | 0.01 | 0 | 0 | 0 | 0 | |
Free cash flow yield | 0 | 0 | -0.01 | -0.01 | 0.04 | |
Debt to equity | 0.03 | 0.03 | 0.03 | 0.03 | 0.11 | |
Debt to assets | 0.03 | 0.03 | 0.03 | 0.03 | 0.08 | |
Net debt to EBITDA | -4.29 | -40.15 | -8.88 | -18.13 | -10.4 | |
Current ratio | 3.77 | 4.34 | 3.61 | 3.45 | 2.75 | |
Interest coverage | 65.81 | 22.88 | 37.22 | 7.01 | 301.78 | |
Income quality | 1 | 1 | -1.58 | -4.91 | 84.63 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0.01 | 0.09 | 0.64 | 0.06 | 5.12 | |
Sales general and administrative to revenue | -0.07 | 0.12 | -0.07 | 0.31 | -0.12 | |
Research and developement to revenue | 0.05 | 0.04 | 0.05 | 0.05 | 0.04 | |
Intangibles to total assets | 0.2 | 0.2 | 0.2 | 0.2 | 0.19 | |
Capex to operating cash flow | -1.29 | -0.92 | 0.17 | 0.5 | -0.22 | |
Capex to revenue | -0.16 | -0.03 | -0.04 | -0.12 | -0.18 | |
Capex to depreciation | -4.51 | -0.28 | -0.43 | 0.55 | -3.07 | |
Stock based compensation to revenue | 0.02 | 0 | 0.02 | -0.03 | 0 | |
Graham number | 6.35 | 1.85 | 4.21 | 2.28 | 1.47 | |
ROIC | 0.03 | 0 | 0.01 | 0 | 0 | |
Return on tangible assets | 0.03 | 0 | 0.01 | 0 | 0 | |
Graham Net | 2.64 | 2.68 | 2.6 | 2.48 | 2.52 | |
Working capital | 4.03B | 4.11B | 4.05B | 4.07B | 4.01B | |
Tangible asset value | 6.08B | 6.11B | 6.16B | 6.16B | 6.22B | |
Net current asset value | 3.7B | 3.78B | 3.85B | 3.88B | 3.9B | |
Invested capital | 0.03 | 0.03 | 0.03 | 0.03 | 0.11 | |
Average receivables | 3.09B | 2.93B | 3.23B | 3.48B | 3.38B | |
Average payables | 1.19B | 950.27M | 930.26M | 1.05B | 1.13B | |
Average inventory | 905.46M | 771.87M | 805.48M | 974.14M | 1.04B | |
Days sales outstanding | 146.19 | 537.07 | 489.75 | 548.99 | 254.52 | |
Days payables outstanding | 70.89 | 210.65 | 183.03 | 231.34 | 113.4 | |
Days of inventory on hand | 56.25 | 175.48 | 164.13 | 219.93 | 100.82 | |
Receivables turnover | 0.62 | 0.17 | 0.18 | 0.16 | 0.35 | |
Payables turnover | 1.27 | 0.43 | 0.49 | 0.39 | 0.79 | |
Inventory turnover | 1.6 | 0.51 | 0.55 | 0.41 | 0.89 | |
ROE | 0.03 | 0 | 0.01 | 0 | 0 | |
Capex per share | -0.29 | -0.02 | -0.03 | -0.07 | -0.21 |
002389.SZ Frequently Asked Questions
What is Aerospace CH UAV Co.,Ltd stock symbol ?
Aerospace CH UAV Co.,Ltd is a CN stock and trading under the symbol 002389.SZ
What is Aerospace CH UAV Co.,Ltd stock quote today ?
Aerospace CH UAV Co.,Ltd stock price is $16.5 today.
Is Aerospace CH UAV Co.,Ltd stock public?
Yes, Aerospace CH UAV Co.,Ltd is a publicly traded company.